PMID- 35669157 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220716 IS - 2522-8307 (Electronic) IS - 1110-0591 (Print) IS - 1110-0591 (Linking) VI - 46 IP - 1 DP - 2022 TI - The association between different predictive biomarkers and mortality of COVID-19. PG - 158 LID - 10.1186/s42269-022-00844-7 [doi] LID - 158 AB - BACKGROUND: Immunocompromised individuals are expected to be more prone to severe diseases and, subsequently, death. Genetic disorders and polymorphisms in genes involved in the immune system, such as human leukocyte antigen (HLA), inflammatory cytokines, and killer-cell immunoglobulin-like receptors, can be involved in the immune system's response to various pathogens. In the current survey, the data were received from the world health organization, collected around the world. RESULTS: Spearman's coefficient correlation test for evaluating the relationship between the Daily Death Rates (DDR) and immunological variables showed a statistically significant correlation between the DDR and all immunological variables except TNFa857T, TNFa863A IL2330G, and IL2166T (P < 0.001). Also, there was a statistically significant correlation between the DDR and some HLA markers. CONCLUSION: This meta-analysis study shows that predictive biomarkers and mortality of COVID-19 are associated with HLA markers. However, these results should be confirmed in a more structured agreement. It is worth noting that the design of new studies should consider potential diseases with poor prognoses because they are related to these immune genetic markers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s42269-022-00844-7. CI - (c) The Author(s) 2022. FAU - Ansari, Narges AU - Ansari N AD - Department of Internal Medicine, Isfahan Bone Metabolic Disorders Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. GRID: grid.411036.1. ISNI: 0000 0001 1498 685X FAU - Jahangiri, Mina AU - Jahangiri M AD - Department of Biostatistics and Epidemiology, Faculty of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. GRID: grid.411230.5. ISNI: 0000 0000 9296 6873 FAU - Shirbandi, Kimia AU - Shirbandi K AD - Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. GRID: grid.411230.5. ISNI: 0000 0000 9296 6873 FAU - Ebrahimi, Mina AU - Ebrahimi M AD - Thalassemia and Hemoglobinopathy Research Centre, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. GRID: grid.411230.5. ISNI: 0000 0000 9296 6873 AD - Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. GRID: grid.411230.5. ISNI: 0000 0000 9296 6873 FAU - Rahim, Fakher AU - Rahim F AUID- ORCID: 0000-0002-2857-4562 AD - Thalassemia and Hemoglobinopathy Research Centre, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. GRID: grid.411230.5. ISNI: 0000 0000 9296 6873 LA - eng PT - Journal Article DEP - 20220531 PL - Germany TA - Bull Natl Res Cent JT - Bulletin of the National Research Centre JID - 101755158 PMC - PMC9152825 OTO - NOTNLM OT - Biomarker OT - COVID-19 OT - HLA OT - Polymorphism COIS- Competing interestsThe authors declare that they have no competing interests. EDAT- 2022/06/08 06:00 MHDA- 2022/06/08 06:01 PMCR- 2022/05/31 CRDT- 2022/06/07 02:26 PHST- 2021/11/11 00:00 [received] PHST- 2022/05/13 00:00 [accepted] PHST- 2022/06/07 02:26 [entrez] PHST- 2022/06/08 06:00 [pubmed] PHST- 2022/06/08 06:01 [medline] PHST- 2022/05/31 00:00 [pmc-release] AID - 844 [pii] AID - 10.1186/s42269-022-00844-7 [doi] PST - ppublish SO - Bull Natl Res Cent. 2022;46(1):158. doi: 10.1186/s42269-022-00844-7. Epub 2022 May 31.